(Press-News.org) La Jolla, CA – Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical cancer.
When tested in several cultured human cell models, HTI-1968 blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to Louise T. Chow, Ph.D. and Thomas Broker, Ph.D., who presented the findings at the Seattle conference. The National Institute of Allergy and Infectious Diseases in the National Institutes of Health funded Chow's work at the University of Alabama, Birmingham.
"HTI-1968 is potent and selective, inhibiting the growth of these high-risk HPV types. Dr. Chow's findings, though early stage, offer hope to millions of women infected by one of these high-risk HPV types, including two that are responsible for 70 percent of cervical cancer cases," said Hera Therapeutics CEO Karl Hostetler, M.D.. Currently surgery is the only therapy available to women who have persistent infection with these types of HPV and show signs of abnormal cells.
Hera Therapeutics is developing a topical, non-surgical approach to treat HPV, which could alter the standard of care while preserving structural integrity of the cervix.
Approximately 96 million people worldwide, men and women, are infected with HPV-16 or HPV-18, according to the Centers for Disease Control. Almost 4,000 women in the U.S. die from invasive cervical cancer each year, according to the CDC.
While cervical cancer vaccines prevent infection from the disease, they are not approved by the FDA for marketing to people over 26-years-old and have not demonstrated efficacy in people already infected with the HPV virus.
INFORMATION:
About Hera Therapeutics Inc.
Using a new medicinal chemistry platform, Hera Therapeutics Inc. is focused on the research, development and commercialization of direct acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV and animal retroviruses.
Hera Therapeutics was founded in 2012 by Karl Hostetler, M.D., a professor emeritus at University of California, San Diego, who was previously a founder of three biotech companies, including Chimerix, Triangle Pharmaceuticals and Vical.
Hera Therapeutics Inc.
c/o Janssen Labs
3210 Merryfield Row
San Diego, CA 92121
Study shows Hera Therapeutics compound combats HPV types that cause most cervical cancer
2014-08-22
ELSE PRESS RELEASES FROM THIS DATE:
Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections
2014-08-22
(PHILADELPHIA) - A Penn Medicine team has found that targeted automated alerts in electronic health records significantly reduce urinary tract infections in hospital patients with urinary catheters. In addition, when the design of the alert was simplified, the rate of improvement dramatically increased.
The alerts help physicians decide whether their patients need urinary catheters in the first place and then alert them to reassess the need for catheters that have not been removed within a recommended time period. The electronic alert, developed by medical researchers ...
From happiness to pain: Understanding serotonin's function
2014-08-22
In a study published today (August 22nd), in the scientific journal PLoS One, researchers at the Champalimaud Neuroscience Programme establish the effect of serotonin on sensitivity to pain using a combination of advanced genetic and optical techniques.
"Serotonin is a small molecule known to be implicated in a wide range of brain functions, from the control of sleep and appetite, to the regulation of complex emotional behaviours, This neurotransmitter is also popularly thought to contribute to feelings of well being and happiness, as some anti-depression medications work ...
Kessler Foundation study of self-awareness in MS has implications for rehabilitation
2014-08-22
West Orange, NJ. August 22, 2014. A new study of self-awareness by Kessler Foundation researchers shows that persons with multiple sclerosis (MS) may be able to improve their self-awareness through task-oriented cognitive rehabilitation. The study was epublished ahead of print on July 2 in NeuroRehabilitation. (Yael Goverover, Helen Genova, Hali Griswold, Nancy D. Chiaravalloti & John DeLuca: Metacognitive knowledge and online awareness in persons with multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is one's ability to recognize cognitive problems caused by ...
Good news for diabetics who are sick of the finger prick
2014-08-22
WASHINGTON, August 21, 2014 — Diabetes affects nearly 10 percent of the U.S. population. Among the biggest complaints of diabetics: constant finger pricking to test blood glucose levels. Fortunately, research published in ACS Chemical Biology reports the development of a protein that could lead to less pain and more accurate results for diabetes patients. In the American Chemical Society's (ACS') newest Breakthrough Science video, Sylvia Daunert, Ph.D., shows off her "designer protein" that could eventually allow diabetics to check their blood sugar from their iPhones. ...
Tissue regeneration using anti-inflammatory nanomolecules
2014-08-22
Anyone who has suffered an injury can probably remember the after-effects, including pain, swelling or redness. These are signs that the body is fighting back against the injury. When tissue in the body is damaged, biological programs are activated to aid in tissue regeneration. An inflammatory response acts as a protective mechanism to enable repair and regeneration, helping the body to heal after injuries such as wounds and burns. However, the same mechanism may interfere with healing in situations in which foreign material is introduced, for example when synthetics are ...
NASA sees Tropical Storm Karina get a boost
2014-08-22
NASA's TRMM satellite saw Tropical Storm Karina get a boost on August 22 in the form of some moderate rainfall and towering thunderstorms in the center of the storm.
The Tropical Rainfall Measuring Mission or TRMM satellite passed directly above the center of Tropical Storm Karina on August 22, 2014 at 0151 UTC (Aug. 21 at 9:51 p.m. EDT). A rainfall analysis that used data from TRMM's Microwave Imager (TMI) showed that storms near Karina's center were dropping rain at a rate near 25 mm/1 inch per hour. Where the heaviest rainfall was occurring, TRMM spotted a couple ...
New enzyme targets for selective cancer therapies
2014-08-22
(Edmonton) Thanks to important discoveries in basic and clinical research and technological advances, the fight against cancer has mobilized into a complex offensive spanning multiple fronts.
Work happening in a University of Alberta chemistry lab could help find new and more selective therapies for cancer. Researchers have developed a compound that targets a specific enzyme overexpressed in certain cancers—and they have tested its activity in cells from brain tumours.
Chemistry professor Christopher Cairo and his team synthesized a first-of-its-kind inhibitor that ...
Women's health and 'Fifty Shades:' Increased risks for young adult readers?
2014-08-22
New Rochelle, NY, August 21, 2014—Popular fiction that normalizes and glamorizes violence against women, such as the blockbuster Fifty Shades series, may be associated with a greater risk of potentially harmful health behaviors and risks. The results of a provocative new study are presented in the article "Fiction or Not? Fifty Shades Is Associated with Health Risks in Adolescent and Young Adult Females," published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health ...
UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment
2014-08-22
CLEVELAND – Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials, according to new recommendations for renal artery stenosis e-published in Catheterization and Cardiovascular Interventions today by the Society for Cardiovascular Angiography and Interventions (SCAI).
University Hospitals Case Medical Center's Sahil Parikh, MD, Director, Interventional Cardiology Fellowship Program and Professor of Medicine, Case Western Reserve University School of Medicine was the lead author ...
Use a rule of thumb to control how much you drink
2014-08-22
AMES, Iowa – Sticking to a general rule of pouring just a half glass of wine limits the likelihood of overconsumption, even for men with a higher body mass index. That's the finding of a new Iowa State and Cornell University study to be published in a forthcoming issue of the International Journal of Drug Policy.
Laura Smarandescu, lead author and an assistant professor of marketing at Iowa State, says the research team looked at a variety of factors to understand and control over pouring. Researchers found BMI affected how much men poured, but had no influence on women. ...